Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025
   Core EBITDA Margin(%) 14.3111.56

What is the latest Core EBITDA Margin ratio of FREDUN PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of FREDUN PHARMACEUTICALS is 14.31 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar202614.31
Mar202511.56

How is Core EBITDA Margin of FREDUN PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2026 14.31
23.79
Mar2025 11.56 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹1,639.8 Cr 15.4% 17.7% 239.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,870.0 Cr 0.8% 8.3% 17.1% Stock Analytics
DIVIS LABORATORIES ₹194,316.0 Cr 7.1% 9% 4.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹169,316.0 Cr 2% 12.1% 49.6% Stock Analytics
CIPLA ₹115,477.0 Cr -0.7% 4.1% -3.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,156.0 Cr -1.7% -4.2% -3.1% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

15.4%

17.7%

239.6%

SENSEX

0.6%

1.2%

-7.8%


You may also like the below Video Courses